About Dawatek
Dawatek is a Healthcare company based in Oak Park (United States) founded in 2017 by Davina Moossazadeh and Isaac Chadri. Developer of medical imaging devices to diagnose infectious and chronic diseases. Dawatek has raised $100 thousand across 1 funding round from investors including Gener8tor. Its chief executive, as recorded, is Isaac Chadri. Its focus areas include Life Sciences, Infectious Diseases, Medical Devices and Screening. Its competitors include Scholar Rock, Fluxion Biosciences and Ionpath; 3 of its 3 listed competitors have raised funding.
Company details
Dawatek was founded in 2017 in Oak Park, United States, as a developer of medical imaging devices focused on infectious and chronic diseases. Devices such as RTK-19 are utilized for detecting bacterial, viral conditions, cancer, and COVID-19, while RIM-25 is employed for scanning the human body to identify oral cancer. Operations center on healthcare technology innovation within the medical diagnostics sector.
- Headquarters Oak Park, United States
- Founders Davina Moossazadeh, Isaac Chadri
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dawatek.com
- Social LinkedIn X
- Total Equity Funding$100K (USD)
in 1 rounds
- Latest Funding Round$100K (USD), Seed
Sep 2022
- Investors
Funding Insights of Dawatek
Dawatek has successfully raised a total of $100K through 1 strategic funding round. The most recent funding activity was a Seed round of $100 thousand completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $100,000
- Total Rounds 1
- Last Round Seed — $100,000
- First Round $100,000
(Sep 2022)
- Investors Count 1
All 1 funding rounds of Dawatek with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $100,000 | Seed | – | Gener8tor | – |
1 investors in total: 1 institutional.
Investors in Dawatek
Dawatek has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Gener8tor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are accelerated via a 12-week program with funding support. | 2012 | gener8tor.com | Madison, United States |
Investor details for Dawatek
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dawatek
2 people are tracked at Dawatek (2 in leadership).
| Name | Role | Group |
|---|---|---|
Davina Moossazadeh | Co-Founder & CTO | Leadership |
Isaac Chadri | Co-Founder & CEO | Leadership |
Complete people profiles for Dawatek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dawatek
2 dated milestones of Dawatek across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Dawatek is founded.
- Funding First funding round of $100K.
Competitors of Dawatek
Dawatek has 3 listed competitors in our database, 3 of them funded. They include Scholar Rock, Fluxion Biosciences and Ionpath.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| scholarrock.com | 2012 | Cambridge, United States | $103.3M | 150 | Antibody-based drugs for primary myopathies are developed and targeted. | |
| fluxionbio.com | 2005 | San Francisco, United States | $20.85M | Microfluidics-based tools for cellular analysis are provided. | ||
| ionpath.com | 2014 | Menlo Park, United States | $18M | 37 | Multiplexed ion beam imaging platform for tissue biopsies is developed. |
Detailed competitors of Dawatek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Dawatek (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dawatek
Dawatek was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Dawatek is headquartered in Oak Park, United States. It is registered at Oak Park, Illinois, United States.
Isaac Chadri is the CEO of Dawatek, as recorded in our data. They have also founded this company.
Dawatek is a funded company, having raised a total of $100K across 1 funding round to date. The company's 1st funding round was a Seed of $100K, raised on Sep 2022.
Dawatek was founded in 2017 in Oak Park, United States, as a developer of medical imaging devices focused on infectious and chronic diseases. Devices such as RTK-19 are utilized for detecting bacterial, viral conditions, cancer, and COVID-19, while RIM-25 is employed for scanning the human body to identify oral cancer. Operations center on healthcare technology innovation within the medical diagnostics sector.
Dawatek's top competitors include Scholar Rock, Ionpath and Fluxion Biosciences.
Dawatek has 1 investor. Key investors include Gener8tor.